688763-67-9

Upstream product

• 276702-70-6 4-(3-Amino-6-chloro-2-hydroxy-benzenesulfonyl)-piperazine-1-carboxylic acid tert-butyl ester 
• 93110-05-5 2-chloro-1-fluoro-3-isocyanatobenzene 
• 934685-42-4 2-chloro-3-fluoro-benzoyl azide 
• 960495-44-7 2-(tert-butyl)-6-chloro-7-(piperazin-1-ylsulfonyl)benzo[d]oxazole 
• 455-38-9 3-fluorobenzoic acid 
• 21900-57-2 2-chloro-3-fluorobenzoic acid chloride 
• 102940-86-3 3-chloro-3-fluorobenzoic acid 

Downstream Products

• 276702-70-6 4-(3-Amino-6-chloro-2-hydroxy-benzenesulfonyl)-piperazine-1-carboxylic acid tert-butyl ester 
• 960495-43-6 Elubrixin tosylate 
• 688763-65-7 Elubrixin hydrochloride 

Relevant academic research and scientific papers

METHOD OF TREATMENT

This invention relates to the use of a sulfonamide substituted diphenyl urea compound to treat cystic fibrosis, or the symptoms associated with cystic fibrosis.

METHOD OF TREATMENT

This invention relates to the use of sulfonamide substituted diphenyl urea compounds to treat endometriosis.

IL-8 RECEPTOR ANTAGONISTS

This invention relates to novel compounds of Formula (I) to (VII), and compositions thereof, useful in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8).